Showing 15 posts of 17 posts found.

Mini-labs to fight counterfeit drugs in Africa

March 2, 2012
Sales and Marketing Africa, Merck KGaA, Zambia, counterfeits

Merck KGaA is donating equipment which can detect counterfeit drugs, while also increasing its commitment to eradicating schistosomiasis in Africa. …

Google fined $500m for online drug advertising

August 26, 2011
Medical Communications, Sales and Marketing Google Adwords, counterfeits, google

Google has been fined $500 million by the US government for allowing pharmacies based in Canada to advertise unlicenced drugs …

Pfizer Real Danger medicine spam

Digital Pharma: Social media boost for Pfizer anti-counterfeits campaign

March 28, 2011
Medical Communications Digital Pharma blog, Pfizer, counterfeits

Pfizer UK is using social media to reinvigorate its Real Danger patient safety campaign. The next phase of the campaign, …

Counterfeit Plavix

Europe votes in new anti-counterfeit law

February 21, 2011
Manufacturing and Production EFPIA, counterfeits, supply chain

The European Parliament has voted in favour of the Falsified Medicines Directive to help stop the flow of counterfeit medicines …

Anti-counterfeiting pilot a success, says EFPIA

May 10, 2010
Sales and Marketing counterfeits, supply chain

A pilot project aimed at stopping counterfeit medicines getting into the supply chain has been a resounding success, according to …

In search of a real solution to the counterfeit problem

May 10, 2010
Manufacturing and Production Plavix, counterfeits, supply chain

For a great deal of the last decade, warnings from the pharmaceutical industry about the growing threat of counterfeit medicines …

EU votes for tighter internet drug regulations

May 4, 2010
Sales and Marketing EU, counterfeits, viagra

The European Parliament has voted to enact stronger legislation against poor quality medicines available on the internet. The move comes …

77 million Europeans fuelling counterfeits market

February 19, 2010
Sales and Marketing Europe, Pfizer, counterfeits

A new survey commissioned by Pfizer shows that Europeans are fuelling a counterfeit medicines market worth €10.5 billion.The findings are …

Blog footer

Digital Pharma: Byte-sized roundup

November 27, 2009
Medical Communications, Sales and Marketing ABPI, counterfeits, digi, digital pharma

The ABPI this week became the latest pharma industry body to launch an official Twitter account, @ABPI_APS.It’s the voice of …

Get real - rat man

Global Awards wins for Langland

November 25, 2009
Medical Communications Bayer, Langland, Pfizer, awards, counterfeits, get real

Windsor-based advertising agency Langland has won three trophies at the prestigious Global Awards for healthcare communications.Two of these were for …

Pfizer's Real Danger campaign

Digital Pharma: Pfizer’s multi-media dead rat

November 4, 2009
Medical Communications Pfizer, counterfeits, digi, get real

Pfizer has given a multi-media boost to its hard-hitting ‘dead rat’ campaign, which warns about the dangers of buying counterfeit …

EFPIA starts anti-counterfeiting pilots in Sweden

October 21, 2009
Manufacturing and Production, Sales and Marketing EU, counterfeits, supply chain

More than 100,000 products and 25 retail pharmacies in Stockholm will take part in a two-month anti-counterfeiting project run by …

EFPIA plans counterfeit crackdown

May 20, 2009
Manufacturing and Production, Research and Development EFPIA, counterfeits

 European pharmaceutical industry association EFPIA has unveiled a new scheme to crack down on counterfeit medicines.Beginning with a trial run …

Advertising regulator clears ‘dead rat’ cinema ad

May 11, 2009
Sales and Marketing counterfeits

Pfizer's hard-hitting advert about the dangers of using counterfeit medicines did not breach advertising regulations, according to the Advertising Standards …

Patients to get counterfeit warning with each prescription

March 31, 2009
Manufacturing and Production counterfeits

New guidance to patients to raise public awareness of fake medicine and its dangers has been launched by the RPSGB …

Latest content